Exagen Inc. XGN Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Exagen Inc.’s reported figures.
Based on trailing twelve months.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s return on equity?
- Exagen Inc. (XGN) reported return on equity of -193.6% in Q1 2026.
- How has Exagen Inc.'s return on equity changed year-over-year?
- Exagen Inc.'s return on equity decreased by 64.7% year-over-year, from -117.5% to -193.6%.
- What is the long-term trend for Exagen Inc.'s return on equity?
- Over 5 years (2020 to 2025), Exagen Inc.'s return on equity has grown at a 34.0% compound annual growth rate (CAGR), from -34.2% to -147.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.